Editor's Picks Analysis & Opinion

Reports Q1 2021 results on Tuesday, Apr. 27, after the close Revenue expectation: $51.38 billion EPS expectation: $15.70 Despite multiple regulatory probes and tightening regulations on how social...

With some of the largest U.S. companies reporting their quarterly earnings in the upcoming week, for investor's it will be all about corporate America and its financial health. About a third of...

This article was written exclusively for Investing.comIt has been one ugly, ugly, day for cryptos. At the time of writing, Doge had lost 25% on the session and XRP was not far off either, being 23%...

All indications point to how US consumers have been spending their stimulus checks in recent weeks.According to the numbers released by the Census Bureau, retail and food services sales increased 9.8%...

This article was written exclusively for Investing.comVolatility levels, as measured by the VIX Volatility Index, have been falling. The index has recently slid to its lowest level since the pandemic...

It isn’t exactly rotational play but investor confidence is bubbling over in agricultural markets, with soybeans leading the three main US crop futures for the best week in almost eight years,...

Vaccines manufactured by three groups have so far been approved in the UK. They include:AstraZeneca (LON:AZN) (NASDAQ:AZN)/ Oxford University; BioNTech (NASDAQ:BNTX) / Pfizer (NYSE:PFE); and Moderna...

At time of writing, European stocks were tracking US shares higher, after yesterday's Wall Street session showed the reflation trade is alive and well and all four major indices rallied.What seems to...